MissionIR Articles
Original content written and distributed as part of our ongoing relationships.
-
CNS Pharmaceuticals (NASDAQ: CNSP) Advances Brain Cancer Drug Candidate and Sponsors Annual SNO Conference
Biotechnology developer CNS Pharmaceuticals is preparing, with its partner WPD Pharmaceuticals, a global set of Phase 2 trials for its drug candidate Berubicin, which has shown promise in combating the effectively fatal glioblastoma multiforme (“GBM”)…
-
MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) to Host 13th Annual LD Micro Main Event on Sequire Virtual Platform
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights to publicly traded companies through Sequire, today announced that it will host the 13th Annual LD Micro Main Event, a prominent two-day virtual…
-
MissionIRNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) to Acquire Mobile Game Developer Fuzhou Csfctech
Blue Hat Interactive (NASDAQ: BHAT), a leading producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, has signed a definitive agreement for the acquisition of 51% of Fuzhou…
-
MissionIRNewsBreaks – Wrap Technologies Inc.’s (NASDAQ: WRAP) Flagship Product — BolaWrap — Captured On Bodycam Video
WrapTechnologies (NASDAQ:WRAP), an innovator of modern policing solutions, announced that BolaWrap(R), its patented, hand-held remote restraint device, was used by the Virginia Police Department in Minnesota earlier this month. The successful deployment of the revolutionary…
-
Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Releases Q3 Financial Results, Corporate Highlights
Financial report notes working capital of $44.7 million at end of Q3 2020, increase of 17% over Q2 2020 Key quarter highlights include becoming debt-free, progress on rare earth elements (“REEs”) CEO reports company making “significant strides…
-
MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Commences Site Recruitment for Upcoming Acclaim-1 Clinical Trial
Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, on Monday announced its commencement of clinical trial site recruitment for its upcoming Acclaim-1 clinical trial for the treatment of non-small…
-
MissionIRNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Appointment of New VP of Translational Medicine
VistaGen Therapeutics (NASDAQ: VTGN) has appointed a new vice president of translational medicine. A pioneer in the development of neuroactive steroids known as pherines, Louis Monti, MD., PhD., developed the original scientific platform that enabled…
-
VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Positive Preclinical Data for Potential Anxiety Treatment
VTGN CEO “even more excited about PH94B’s potential to change lives without the risky side effects and safety concerns of benzos” Study results suggest PH94B’s mechanism of action may not have benzodiazepine-like side effects, such…
-
As World Transitions away from Gas Guzzlers, Net Element Inc. (NASDAQ: NETE) Entering EV Market Through Mullen Technologies Merger
NETE plans to divest payments processing model to enter EV industry through proposed merger with privately-held Mullen Technologies Inc. Merger allows Mullen stakeholders to obtain majority of stock while accelerating process of taking company public,…
-
MissionIRNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Featured in SNN Network Interview
Jupiter Wellness (NASDAQ: JUPW), a leading developer of cannabidiol (“CBD”) based therapeutics and wellness products, today announced that it was featured in a new video interview with SNN Network, “The Official Small-, Micro- and Nano-Cap…
-
MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Advancement of MS1819 Combination Therapy Trial in Turkey
AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that the first two patients have been dosed in Turkey for its Phase 2 trial. The trial…
-
MissionIRNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRTC) to Begin Trading Under Nasdaq Ticker Symbol “WRAP”
Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, today announced that its Nasdaq ticker symbol is set to change from “WRTC” to “WRAP” beginning at market open on Tuesday, December 1, 2020. “We…
-
MissionIRNewsBreaks – Trxade Group Inc.’s (NASDAQ: MEDS) Platform Meets Today’s Demands Through Intelligent Design
Trxade Group NASDAQ: MEDS), an integrated drug-procurement, delivery and health care platform, is ideally situated as the global pandemic has led to a cascade of changes involving how health care is administered, perhaps most notably…
-
MissionIRNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Provide Digital Therapeutics Solution to Employees of Fortune 500 Company
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, will be providing its digital therapeutics solution to qualified employees of a U.S.-based Fortune 500 technology company. The contract, which goes into effect on…
-
Predictive Oncology’s (NASDAQ: POAI) Skyline Medical Sells 15 Streamway(R) Systems in Q3 2020 as COVID-era Drives Need for Sanitation Systems
Closed design of Streamway(R) System provides safety from potential hazards of drips and spills during endoscopy, radiology, cystoscopy, urology procedures The Streamway(R) System reduces costs, minimizes environmental impact of 50 million potentially disease-infected canisters disposed…
-
AzurRx BioPharma Inc. (NASDAQ: AZRX) Planning to Test Immediate Release MS1819 Capsules in Cystic Fibrosis Study
The company plans to add another study arm to its ongoing Phase 2b OPTION 2 clinical study which currently tests delayed release capsules If it receives FDA approval, AzurRx would be able to identify the…
-
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) IND Application for Cancer Drug Berubicin Accepted for Review
CNS Pharmaceuticals wants to obtain FDA authorization for an Investigational New Drug application for drug candidate Berubicin, a novel treatment for Glioblastoma Multiforme Company believes it’s on track to start in Q1 2021 a potentially…
-
MissionIRNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Initiates Clinical Evaluation of CaniSun(TM)
Jupiter Wellness (NASDAQ: JUPW), a developer of cannabidiol (“CBD”) based therapeutics and wellness products, today announced initiation of a clinical study of its CaniSun(TM) sunscreen lotion for the treatment of actinic keratosis (“AK”), the most…
-
MissionIRNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) to Ring Nasdaq Opening Bell
180 Life Sciences (NASDAQ: ATNF, ATNFW), a clinical-stage biotechnology company with its lead indication in phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today…
-
MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Featured in Korea Biomedical Review Article
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, was featured in a recent article published in the Korea…
-
MissionIRNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Begins Strategic Greater Bay Area Expansion
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a leading producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, today announced its entry into an agreement with three…
-
MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Featured in Stock2Me Podcast
AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, was featured in InvestorBrandNetwork’s (“IBN”) latest episode of its Stock2Me Podcast. Stock2Me Podcasts feature a fascinating array of companies…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Discusses Brain Cancer Drug During Syndicated Broadcast
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the central nervous system, is featured in a recent NetworkNewsAudio (“NNA”) broadcast. During the broadcast,…
-
MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present at Diamond Equity Research Emerging Growth Invitational
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it will participate at the Diamond Equity Research Emerging Growth Invitational taking place…
-
MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) to Present at H.C. Wainwright Virtual Mining Conference
Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S.-based uranium mining company, today announced that its president and CEO, Mark S. Chalmers, will present at the H.C. Wainwright Mining Conference slated to be held…
-
MissionIRNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Schedules 2020 Annual General Meeting, Announces Record Revenue, Gross Profit for Q3 2020
iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, on Monday announced the schedule for its 2020 annual general meeting. According to the update, iClick will hold…
-
VistaGen Therapeutics (NASDAQ: VTGN) Seeks to Address Rising Incidence of Mental Health Disorders in United States
VistaGen currently developing three novel drug candidates designed to treat central nervous system disorders Anxiety disorders have been found to affect 18.1% of the U.S. population; however, only 36.9% of those suffering receive treatment Prevalence…
-
The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER) Meets Growing Demand for Single-Serve Beverages with Flagship Alkaline88 Offering
Recent study reports that consumers are opting for single-serve beverages; bottled water outperforms carbonated beverages WTER’s flagship product — Alkaline88 — now available in easy-to-carry, two-liter single-serve bottles Company’s A88 flavor-infused water offering gaining significant market…
-
MissionIRNewsBreaks – Knightscope Inc. K5 to Soon Patrol Arizona Campus
Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”) to enhance U.S. security operations, recently announced that a southern Arizona college will soon deploy a Knightscope K5 security robot to…
-
Net Element Inc. (NASDAQ: NETE) Set to Benefit as China, U.S. Gear up to Promote Electric Vehicle Sales
China’s government has set out its next 5-year plan, highlighting promotion of electric vehicles as key tenet underpinning their environmental policies Net Element’s reverse merger with EV manufacturer Mullen Technologies is expected to close by…
-
MissionIRNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRTC) Announces Expansion of Ballistic Shield Product Line
Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, today announced the expansion of its WRAP Armor(TM) ballistic shield product line to include the Level IIIA Patrol Shield and the Molle Shield Cover in…
-
MissionIRNewsBreaks – Net Element Inc. (NASDAQ: NETE) Featured in Research Report
Net Element (NASDAQ: NETE) was featured in a recent report by Zacks Small-Cap Research that discussed the company’s third quarter showing sequential rebound as the merger proceeds with privately-held Mullen Technologies Inc. The report reads,…
-
MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Eyes Bright Nuclear Future
Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading producer of uranium in the United States, is poised with the unique abilities and resources to supply the nation with its growing demand for clean nuclear…
-
MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) Positioned as Early Entrant in Rapidly Growing Field of Psychedelics
UC Berkeley and other prominent academic institutions, including Johns Hopkins University in Maryland and Imperial College in London, are accelerating scientific research of psilocybin by launching a new center focusing on the compound (https://ibn.fm/VdvfN). Cybin…
-
MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Featured in Simply Wall St Article
AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, was featured in a recent Simply Wall St article. The piece, titled “Is AzurRx BioPharma (NASDAQ:AZRX) In A Good…
-
Falling Battery Prices Pave Way for EV Future; Net Element Inc. (NASDAQ: NETE) Positioned to Profit through Mullen Technologies Merger
EV battery prices becoming increasingly economical, dropping 87% in less than decade with additional 30% drop predicted by 2023 NETE plans to divest payments processing model to enter EV industry through merger with privately-held Mullen…
-
CNS Pharmaceuticals (NASDAQ: CNSP) Outlines Plans for Advancing Drug It Hopes Will Beat Deadly Brain Cancer
Biotechnology developer CNS Pharmaceuticals is working to advance the clinical trials of a novel brain cancer-fighting drug candidate with the aim of developing a new, effective therapy for treating an otherwise incurable disease The company…
-
MissionIRNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Announces Second Partnership to Present Alkaline88(R) Products to Entire Hospitality Channel
The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced that it has added a new foodservice broker, IBA Foodservice. According to…
-
MissionIRNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Enters Strategic Cooperation, Broadening New Product Channels
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a leading producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, today announced that its controlling subsidiary Xunpusen Technology Co.…
-
The Alkaline Water Company’s (NASDAQ: WTER) (CSE: WTER) A88CBD Product Line Perfectly Positioned for Growth in C-Store Space
Sales of CBD products through convenience, gas stores grew by 2,276% in 2019. CBD drinks, valued at $52 million in c-store sales in 2019, are highly popular among new consumers. WTER offers A88CBD(TM) product line…
Search Articles
Latest Articles
- SuperCom Ltd. (NASDAQ: SPCB) U.S. Expansion Positions Company as Strong Investment Opportunity in Expanding Electronic Monitoring (‘EM’) Market
- Datavault AI Inc. (NASDAQ: DVLT) Is ‘One to Watch’
- MissionIRNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS, WLDSW) Announces $4 Million Registered Direct Offering Priced at Market
- HeartBeam Inc. (NASDAQ: BEAT) Advances Power of ECG with High-Fidelity At-Home Heart-Monitoring System
- GlobalTech Corporation (GLTK): Building Value Through AI, Big Data, and Digital Infrastructure